Sucampo Pharmaceuticals, Inc.
SCMP
SCMP was delisted on the 12th of February, 2018.
74 hedge funds and large institutions have $88.8M invested in Sucampo Pharmaceuticals, Inc. in 2013 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 19 increasing their positions, 25 reducing their positions, and 10 closing their positions.
81% more capital invested
Capital invested by funds: $49.1M → $88.8M (+$39.7M)
50% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 10
7% more funds holding
Funds holding: 69 → 74 (+5)
24% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 25
93% less call options, than puts
Call options by funds: $7K | Put options by funds: $95K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
+$10.7M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$1.93M |
| 3 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$1.38M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$908K |
| 5 |
CCM
Consonance Capital Management
New York
|
+$499K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$3.19M |
| 2 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$761K |
| 3 |
Renaissance Technologies
New York
|
-$655K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$341K |
| 5 |
SO
STRS Ohio
Columbus,
Ohio
|
-$283K |
SCMP Hedge Fund Activity: Q4 2013 in Review
74 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Sucampo Pharmaceuticals, Inc. (SCMP) for Q4 2013, worth a combined $88.8M — up 81% from $49.1M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new SCMP positions and 10 closed out — a net gain of 5 holders — while 19 added to existing stakes and 25 trimmed.
The largest buyer was Visium Asset Management, opening a new position worth an estimated $10.7M. The largest seller was Numeric Investors, exiting entirely with an estimated $3.19M sold.
- 74 institutional investors held Sucampo Pharmaceuticals, Inc. (SCMP) as of Q4 2013, up from 69 in Q3 2013.
- Funds reported $88.8M of Sucampo Pharmaceuticals, Inc. stock for Q4 2013, up 81% quarter-over-quarter.
- 15 funds opened new Sucampo Pharmaceuticals, Inc. positions in Q4 2013 and 10 closed out, a net change of +5 holders.
- The largest Sucampo Pharmaceuticals, Inc. buyer in Q4 2013 was Visium Asset Management, an estimated $10.7M added.
- The largest Sucampo Pharmaceuticals, Inc. seller in Q4 2013 was Numeric Investors, an estimated $3.19M sold.
Based on aggregated 13F filings for Q4 2013.